Allscripts Adjusts 2015 Guidance

(RTTNews) - Allscripts (MDRX) announced, for fiscal 2015, the company now expects: revenue between $1.390 billion and $1.405 billion; adjusted EBITDA between $238 million and $245 million; and Non-GAAP earnings per share between $0.45 and $0.47 per share. In August, the company projected its 2015 revenue in a range of of $1.40 billion to $1.43 billion and adjusted earnings range of $0.42 to $0.50 per share.

For the third-quarter 2015, bookings were $272 million, a third-quarter record, compared with $223 million in the third quarter of 2014, a 22 percent increase. Sales were strong across core clinical and financial solutions, population health management and managed services.

Revenue totaled $355 million, an increase of 3 percent. Recurring revenue, consisting of subscriptions, recurring transactions, support and maintenance, and recurring managed services, increased 6 percent year over year.

Reflecting year-over-year revenue growth, gross margin expansion and management of operating expenses, adjusted EBITDA increased 44 percent to $66 million in the third quarter of 2015, compared with $46 million in the third quarter of 2014.